(Stroke. 1999;30:2464-2471.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, UMass Memorial Health Care and University of Massachusetts Medical School, Worcester, Mass.
Correspondence to Fuhai Li, MD, Department of Neurology, UMass Memorial Health Care, 119 Belmont St (Memorial Campus), Worcester, MA 01605 E-mail fhli{at}wpi.edu
| Abstract |
|---|
|
|
|---|
MethodsRats were subjected to 60, 90, and 120 minutes of transient MCAO (n=8 per group), permanent MCAO (n=8 per group, 5 groups), and permanent hypothalamic occlusion, in which an occluder was inserted 15 to 15.5 mm to block only the hypothalamic branch from the internal carotid artery (n=4) with the use of the intraluminal suture MCAO method. In one group undergoing permanent MCAO, the body temperature was maintained at 37°C throughout the experiment. In another group (n=4) undergoing 90 minutes of temporary MCAO, diffusion- and perfusion-weighted imaging were performed to document the in vivo ischemic changes in the hypothalamus. Body temperature was measured hourly for 12 hours. At 24 hours (12 hours in 2 permanent MCAO groups), triphenyltetrazolium chloride staining was used to verify ischemic hypothalamic injury and to calculate corrected infarct volumes.
ResultsSpontaneous hyperthermia (>39°C) occurred in the 120-minute group, all permanent MCAO groups, and the hypothalamic occlusion group but not in the 60-minute or the 90-minute groups. Hypothalamic infarction was found in 1 rat each in the 60-minute and 90-minute groups, 6 of the 8 rats in the 120-minute group, 37 of the 40 rats in the permanent occlusion groups, and all 4 rats in the hypothalamic occlusion group. After 90 minutes of transient MCAO, the decreased cerebral blood flow and apparent diffusion coefficient values in the hypothalamic region during occlusion recovered fully 2 hours after reperfusion. The corrected infarct volumes were identical in all permanent occlusion groups.
ConclusionsThe intraluminal suture MCAO lasting for
2 hours
induces spontaneous hyperthermia that is associated with hypothalamic
injury, and delayed spontaneous hyperthermia does not increase infarct
volume after permanent intraluminal suture MCAO.
Key Words: cerebral ischemia, focal hyperthermia middle cerebral artery occlusion rats
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Focal Brain Ischemia
Focal brain ischemia was induced by the intraluminal
suture MCAO method as previously described.1 2 Briefly,
the right CCA, ICA, and ECA were exposed through a midline incision of
the neck. A 4-0 silicone-coated nylon suture was used as an occluder
and was inserted via the CCA (CCA route) or ECA (ECA route). For the
CCA occlusion route, the proximal portions of the right CCA and the ECA
were ligated with 5-0 surgical sutures, and the occluder was inserted
through an arteriotomy of the right CCA 3 mm below the carotid
bifurcation. For the ECA occlusion route, the occluder was inserted
through a stump of the ECA, and the CCA was kept open and intact. The
occluder was advanced into the ICA 17 to 19 mm beyond the carotid
bifurcation. Mild resistance indicated that the occluder was properly
lodged in the anterior cerebral artery and thus blocked blood flow to
the middle cerebral artery (MCA). For temporary MCAO, reperfusion was
obtained by withdrawing the suture approximately 10 mm. For
hypothalamic occlusion, the suture was inserted through an arteriotomy
of the right CCA 3 mm below the carotid bifurcation and advanced
into the ICA only 15 to 15.5 mm above the carotid bifurcation.
Experimental Protocol
Animals were randomly assigned to the 9 experimental groups, as
shown in Table 1
. To determine whether
spontaneous hyperthermia is dependent on the duration of
ischemia, rats were subjected to 60 (group A), 90 (group B), or
120 (group C) minutes of transient MCAO or permanent MCAO (group D).
Group E was designed to determine whether hyperthermia could be avoided
when relatively long periods of anesthesia were given.
Group F (with controlled normothermia) and group G (without temperature
control for 12 hours after permanent MCAO) were used to determine
whether spontaneous hyperthermia increases infarct size. Group H was
used to determine whether hyperthermia could be avoided when the suture
occluder was inserted via the ECA and the CCA remained open and intact.
Group I was designed to determine whether occluding the hypothalamic
vasculature alone induces spontaneous hyperthermia. The rats' body
temperature was maintained at 37°C for the initial 6 hours in group E
and for the entire 12 hours in group G by means of a thermostatically
controlled heating lamp with the animals under anesthesia.
Animals in the other groups were allowed to recover from
anesthesia after surgical procedures that ended at 60
minutes after MCAO in the permanent MCAO groups and the permanent
hypothalamic occlusion group or that terminated right after reperfusion
in the temporary MCAO groups. After the surgical procedures, the rats
were returned to their cages, where a room temperature of 22°C to
24°C was constantly maintained. Rectal temperature was measured
hourly for 12 hours in all groups and at 24 hours in all groups but
groups F and G (12 hours of survival). A microprocessor thermometer
with 0.1°C resolution (Omega Engineering, Inc) was used to
measure rectal temperature by inserting the rectal probe to a depth of
6.5 cm.15 To investigate the in vivo ischemic
changes in the hypothalamic regions caused by the intraluminal suture
occluder, 4 other rats who were subjected to 90 minutes of temporary
MCAO underwent diffusion-weighted (DWI) and perfusion-weighted MRI
(PWI). After MCAO, the animals were fixed to a head holder with a tooth
bar and ear bars and quickly placed into the magnet bore. Inside the
magnet, anesthesia was maintained with 1.0% isoflurane
delivered in air at 1.0 L/min. Body temperature was continuously
monitored with a rectal probe and was maintained at 37°C by means of
a thermostatically regulated heated-air flow system. The rats were
reperfused by withdrawing the occluder in the magnet bore 90 minutes
after MCAO. Animals dying prematurely or having subarachnoid
hemorrhage at postmortem examination were excluded and
replaced.
|
MRI Measurements
The MRI studies were performed in a GE CSI-II 2.0-T/45-cm
imaging spectrometer (GE NMR Instruments) operating at 85.56 MHz for
1H and equipped with ±20 G/cm self-shielding
gradients. Pulsed-field gradient nuclear MR was used to noninvasively
measure diffusion rates of brain water.16 Eight contiguous
coronal slices of DWI, 2 mm in thickness, were acquired with a
spin-echo echo-planar imaging (EPI) sequence (field of view [FOV],
25.6x25.6 mm2; matrix size, 64x64 pixels;
repetition time [TR], 5 seconds; echo time [TE], 74 ms; EPI data
acquisition time, 65 ms; signal averages, 2). Half-sineshaped
gradients were applied along 1 of 3 orthogonal axes. Nine b values,
ranging from 18 to 1553 s/mm2, were used to
measure apparent diffusion coefficient (ADC) of water along each of the
3 orthogonal gradient axes. The average ADC
(ADCav) was calculated by averaging the ADC
values from the 3 orthogonal gradient axes on a pixel-by-pixel
basis,17 and ADCav maps were
generated.18
T2-weighted EPI was used to perform dynamic contrast-enhanced PWI for documenting local cerebral blood flow (CBF). Four contiguous, coronal slices in 2-mm thickness that correspond to the central 4 DWI slices were acquired. A set of 40 images (FOV, 25.6x25.6 mm2; matrix size, 64x64 pixels; TR, 900 ms; TE, 74 ms; EPI data acquisition time, 65 ms; signal average, 1) was obtained for each slice. A bolus injection of 0.25 mL gadopentetate dimeglumine was administered after acquisition of the 15th image. The CBF index (CBFi) were calculated from the PWI data by a previously described method,19 and CBFi maps were generated.
DWI followed by PWI was acquired at 30, 80, 150, and 210 minutes after MCAO. The CBFi and ADCav values were measured (4x4 pixels in size) in both the ipsilateral and homologous contralateral hypothalamic regions on the corresponding maps.
Postmortem Infarct Volume Calculation
At 12 hours in groups F and G and 24 hours in the other groups
after MCAO, the rats were reanesthetized with an
intraperitoneal injection of 400 mg/kg chloral
hydrate and decapitated. The brains were removed and coronally
sectioned into 6 slices with 2-mm thickness. The brain slices were
incubated for 30 minutes in a 2% solution of
triphenyltetrazolium chloride (TTC) at
37°C and fixed by immersion in a 10% buffered formalin
solution.20 Then the brain slices were photographed with
the use of a charge-coupled device camera. The unstained areas were
defined as infarcted. With the use of an image analysis program
(Bio Scan OPTIMAS), the corrected infarct volumes were calculated to
compensate for brain edema as previously
described.21 22
Determination of Hypothalamic Damage
From the TTC-stained brain slices (usually the fourth slice),
one investigator (T.O.), familiar with the anatomic location of the
hypothalamus and not aware of the group assignment, determined whether
ipsilateral hypothalamic injury occurred. The normal hypothalamus
stained dark red. Pink or unstained (white) hypothalamus was judged to
indicate ischemic injury.
Statistical Analysis
Data are presented as mean±SD. Statistical
analyses were performed with the use of a t test and
1-factor or 2-factor repeated-measures ANOVA. A 2-tailed value of
P<0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
During surgical procedures, temperature in all groups was normal
(37°C). The rats usually recovered from anesthesia
approximately 2 hours after the surgical procedures terminated. As
shown in Figure 1
, there was no
hyperthermia (<38°C) in group A (60-minute occlusion) and group B
(90-minute occlusion). However, as rats recovered from
anesthesia, the temperature gradually rose and reached
39°C in group C (120-minute occlusion) at 8 hours and in group D
(permanent occlusion via the CCA) at 5 hours after MCAO. In group E,
hyperthermia (
39°C) occurred 4 hours after the initial 6 hours of
anesthesia was stopped. The temperature in group F was
maintained in the normal range (37°C) throughout the 12-hour
observation period. Hyperthermia also occurred in group G (permanent
occlusion via the CCA) and group H (permanent occlusion via the ECA) at
4 hours after MCAO. Interestingly, the temperature reached 39°C at 5
hours after MCAO in group I, in which the occluder was intentionally
advanced only 15 to 15.5 mm to occlude the hypothalamic branch
originating from the ICA.
|
The identification of hypothalamic injury is shown in Table 3
. One of the 8 rats in each group
undergoing focal ischemia for 60 and 90 minutes was judged to
have hypothalamic infarction. Six of the 8 rats undergoing 120 minutes
of temporary MCAO and 37 of the 40 rats undergoing permanent MCAO had
hypothalamic infarction. All 4 rats that were subjected to hypothalamic
artery occlusion had ischemic injury of the hypothalamus.
Representative TTC staining of the hypothalamus is
shown in Figure 2
.
|
|
The mean CBFi values from all 4 rats demonstrated
by perfusion imaging decreased significantly in the hypothalamic region
(43±8% of contralateral region; P<0.001) as well as the
MCA territory during MCAO; values revealed almost full recovery 2 hours
after reperfusion (210 minutes after occlusion) in the hypothalamic
area (93±13% of contralateral region; P=0.33) but not in
the MCA territory. The mean ADCav values from all
4 rats also declined significantly (65±8% of contralateral region;
P=0.02) after MCAO and almost completely normalized after
reperfusion (95±9% of contralateral region; P=0.52).
Postmortem TTC staining at 24 hours after MCAO demonstrated no
hypothalamic damage in all 4 rats. Representative
CBFi and ADCav maps and TTC
staining from one rat undergoing 90 minutes of transient MCAO are shown
in Figure 3
.
|
The ischemic infarct volumes in each group are shown in Figure 4
. The corrected infarct volume was
significantly smaller in the 60-minute group (P=0.026,
t test) and the 90-minute group (P=0.024,
t test) compared with the permanent occlusion group (group
D). There was no significant difference in infarct size between the
120-minute group and the permanent occlusion group (group D)
(P=0.65, t test). The corrected infarct volume
was almost identical among all permanent occlusion groups
(P=0.98, 1-factor ANOVA), despite different occlusion routes
(CCA versus ECA), different survival times (12 versus 24 hours), and
different body temperatures (controlled normothermia versus spontaneous
hyperthermia). The ischemic infarct size was variable in
the 60-minute occlusion group (coefficient of variation
[SD/mean]=48%), while the infarct sizes in the 90-minute,
120-minute, and permanent occlusion groups were reproducible
(coefficient of variation=15% to 25%).
|
| Discussion |
|---|
|
|
|---|
Many years after introduction of the intraluminal suture MCAO model, 3
separate studies first observed that intraluminal suture MCAO could
induce hyperthermia (>39°C).23 24 25 Zhao et
al7 then reported that the body temperature rose to nearly
39°C after 1 hour of temporary MCAO and reached 39°C to 39.5°C
after 2 hours of temporary or permanent MCAO in Wistar rats. It has not
been proven that spontaneous hyperthermia is related to a specific rat
strain or a specific type of filament occluder.7 Using
Sprague-Dawley rats, we demonstrated that a gradual rise in body
temperature occurred and reached 39°C as the rats recovered from
anesthesia after 2 hours of temporary or permanent
intraluminal suture MCAO, indicating that spontaneous hyperthermia is
not related to the rat strain. Kuluz et al23 previously
demonstrated that MCAO induced by an uncoated 3-0 suture leads to
spontaneous hyperthermia. In a preliminary study, we tested uncoated
3-0, uncoated 4-0, poly-L-lysinecoated 3-0, and
silicone-coated 6-0 suture occluders and found that these different
kinds of sutures also induced hyperthermia after permanent MCAO (data
not shown), suggesting that spontaneous hyperthermia is not unique to
the occluder types. In addition, spontaneous hyperthermia occurred when
the suture occluder was inserted via either the CCA or the
ECA,23 which indicates that an open and intact CCA does
not prevent spontaneous hyperthermia. Interestingly, <90 minutes of
temporary MCAO does not give rise to hyperthermia, consistent
with a recent report.8 Our results, along with
others,7 8 23 24 25 demonstrate that spontaneous
hyperthermia is related to the duration of MCAO and is likely a general
complication of the intraluminal suture MCAO model, if MCAO lasts for
2 hours. It was reported that hyperthermia could be avoided if
anesthesia was used to maintain normal temperature during
ischemia and the first hour of reperfusion after 1 hour of
transient MCAO and if anesthesia plus temperature control
was maintained for the initial 3 hours after MCAO or external cooling
was performed for the initial 4 hours after 2 hours of transient
MCAO.7 However, the present study demonstrates that
spontaneous hyperthermia after permanent MCAO still develops after the
rats recovered from anesthesia even though a normal
temperature was maintained for 6 hours under anesthesia,
suggesting that anesthesia only masks spontaneous
hyperthermia and fails to prevent it after permanent MCAO.
What are the possible mechanisms of spontaneous hyperthermia? It is
unlikely that hyperthermia is caused by an infection since spontaneous
hyperthermia occurred quickly in rats undergoing
2 hours of MCAO and
did not develop in rats undergoing sham operation, in which the suture
occluder was inserted only 2 mm above the carotid
bifurcation,23 and
90 minutes of temporary MCAO, as
demonstrated by our study and others.7 8 One study
previously demonstrated that interfering with blood flow to the brain
temperature regulatory center in the hypothalamus could change the body
temperature.26 Using autoradiographic
technique, Zhao et al7 demonstrated a reduction of blood
flow in the hypothalamus after suture MCAO. The blood supply to the
hypothalamus originates from the anterior cerebral artery, the
ICA, and the posterior communicating artery.27
Accordingly, when the suture occluder is inserted to block the blood
flow to the MCA, it simultaneously interrupts blood flow to
the hypothalamus as well. Hypothalamic damage after insertion of a
filament suture into the ICA to occlude the MCA was documented in
previous studies.7 28 29 Our results confirm that the
ischemic injury in the hypothalamus is likely an important
factor for spontaneous hyperthermia seen with the intraluminal suture
MCAO model, as suggested by the following observations: first,
hyperthermia is closely related to hypothalamic damage after
intraluminal MCAO. In the groups (60- and 90-minute) without
hyperthermia, only 2 of the 16 rats were observed to have hypothalamic
damage. In the groups (120-minute and permanent) with hyperthermia,
however, 43 of the 48 rats had hypothalamic injury. Second, when the
suture occluder was intentionally inserted only 15 to 15.5 mm to
occlude the vascular branch from the ICA to the hypothalamus, all 4
rats had hypothalamic damage and hyperthermia. Third, in the rats
undergoing 90 minutes of temporary MCAO, the CBF and ADC values
demonstrated by in vivo MRI study in the hypothalamic region
significantly decreased during MCAO and fully recovered after
reperfusion. Consequently, no hypothalamic injury was seen at
postmortem TTC staining (Figure 3
). This indicates that the
hypothalamus is likely to tolerate 90 minutes of temporary
ischemia in this model, probably because of its multiple
vascular supply. More than 2 hours of ischemia, however,
appears to be beyond the critical threshold of hypothalamic neurons,
and subsequent ischemic damage in hypothalamus develops.
Further studies are needed to address why hypothalamic damage
consistently results in hyperthermia rather than hypothermia
and whether hypothalamic damage affects plasma glucose levels, since we
did not measure this variable in the present study.
Another interesting finding in this study is that the ischemic infarct volume in the group with controlled normothermia for 12 hours was almost identical to that in the groups with delayed spontaneous hyperthermia with a 12-hour survival or 24-hour survival after permanent MCAO. This indicates that delayed spontaneous hyperthermia does not increase ischemic infarct volume. Many previous studies demonstrated that mild early artificial hyperthermia in brain tissues (39°C) exacerbates both the severity and extent of ischemic damage after global forebrain ischemia.9 10 30 The effect of hyperthermia on ischemic infarct volume after focal brain ischemia is controversial. Using a model of direct MCA clipping or electrocoagulation, Morikawa et al31 observed that hyperthermia significantly increased infarct volume after 2 hours of transient MCAO but not permanent MCAO when brain temperature was modulated to 39°C. However, when the brain and body temperatures were elevated to 40°C before or immediately after occlusion, the infarct volumes significantly increased compared with the normothermia group.11 With the intraluminal suture MCAO model, a temperature of 39.2°C augmented infarct volumes significantly after 90 minutes of temporary MCAO.22 A recent study demonstrated that a delayed postischemic elevation of 40°C, but not 39°C, worsened pathological outcome after 60 minutes of transient MCAO.32 These findings suggest that the detrimental effects of hyperthermia on histopathological outcomes are likely related to the severity of ischemia, duration of ischemia, and degree of hyperthermia. Although it is not conclusive why the spontaneous hyperthermia observed in this study does not aggravate ischemic outcome, several possible explanations can be drawn. First, the extent of ischemic damage is mainly determined by the severity and duration of ischemia, despite the fact that other factors such as hyperthermia9 or hyperglycemia33 34 may aggravate it. However, when the degree of ischemia is severe and the duration is prolonged, for example, in intraluminal suture permanent MCAO, the infarct volume may be almost maximal because of the large artery involved and degree of blood flow impairment. Therefore, other adverse factors may fail to increase infarct volume. Second, there may be a temperature threshold for exacerbating pathological outcomes, as discussed previously. The spontaneous hyperthermia (<40°C) documented in this study may not reach the threshold needed to increase ischemic infarct volume. Furthermore, it is not known whether hyperthermia developed in the brain tissue since we did not measure the brain temperature directly because this would have required an invasive procedure for inserting a needle thermistor in awake rats. Although the body temperature was maintained as normal, brain temperature in the ischemic regions may decrease by 1°C to 2°C after focal ischemia without modulation of brain temperature, as a previous study demonstrated.31 Therefore, the brain temperature in the rats with elevated rectal temperature (39°C to 39.5°C) may have increased just slightly. Finally, it is not known whether delayed spontaneous hyperthermia has the same adverse effects on pathological outcomes as artificial early hyperthermia does. In this study we did not determine the infarct volumes at delayed time points (for instance, 2 or 4 weeks). Further studies are needed to address whether spontaneous hyperthermia has delayed effects on ischemic damage. In addition, studies are also needed to determine whether spontaneous hyperthermia aggravates ischemic outcomes in the transient MCAO model, since artificial hyperthermia may worsen ischemic damage in transient ischemia more than in permanent ischemia.31
In conclusion, the present study demonstrated that spontaneous hyperthermia after the intraluminal suture MCAO is related to the duration of ischemia, is apparently associated with ischemic damage of the hypothalamus, and does not increase the ischemic infarct volume in permanently occluded rats with the suture MCAO model.
| Acknowledgments |
|---|
Received May 4, 1999; revision received August 2, 1999; accepted August 5, 1999.
| References |
|---|
|
|
|---|
2.
Zea Longa E, Weinstein PR, Carlson S, Cummins R.
Reversible middle cerebral artery occlusion without craniectomy in
rats. Stroke. 1989;20:8491.
3.
Laing RJ, Jakubowski J, Laing RW. Middle cerebral
artery occlusion without craniectomy in rats: which method works best?
Stroke. 1993;24:294298.
4. Takano K, Tatlisumak T, Bergmann AG, Gibson DG III, Fisher M. Reproducibility and reliability of middle cerebral artery occlusion using a silicon-coated suture (Koizumi) in rats. J Neurol Sci. 1997;153:811.[Medline] [Order article via Infotrieve]
5.
Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD.
Middle cerebral artery occlusion in the rat by intraluminal suture:
neurological and pathological evaluation of an improved model.
Stroke. 1996;27:16161623.
6.
Nagasawa H, Kogure K. Correlation between cerebral
blood flow and histologic changes in a new rat model of middle cerebral
artery occlusion. Stroke. 1989;20:10371043.
7. Zhao Q, Memezawa H, Smith M-L, Siesjö BK. Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res. 1994;649:253259.[Medline] [Order article via Infotrieve]
8.
Schmid-Elsaesser R, Zausinger S, Hungerhuber E,
Baethmann A, Reulen H-J. A critical reevaluation of the intraluminal
thread model of focal cerebral ischemia: evidence of
inadvertent premature reperfusion and subarachnoid
hemorrhage in rats by laser-Doppler flowmetry.
Stroke. 1998;29:21622170.
9. Minamisawa H, Smith M-L, Siesjö BK. The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol. 1990;28:2633.[Medline] [Order article via Infotrieve]
10.
Dietrich WD, Busto R, Valdes I, Loor Y. Effects of
normothermic versus mild hyperthermic forebrain
ischemia in rats. Stroke. 1990;21:13181325.
11.
Chen H, Chopp M, Welch KMA. Effect of mild hyperthermia
on the ischemic infarct volume after middle cerebral artery
occlusion in the rat. Neurology. 1991;41:11331135.
12. Castillo J, Martinez F, Leira R, Prieto JM, Lema M, Noya M. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc Dis. 1994;4:6671.
13.
Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli
L, Re G, D'Alessandro R. Fever in acute stroke worsens prognosis: a
prospective study. Stroke. 1995;26:20402043.
14. Reith J, Jøgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422425.[Medline] [Order article via Infotrieve]
15. Miyazawa T, Hossmann K-A. Methodological requirements for accurate measurements of brain and body temperature during global forebrain ischemia of rat. J Cereb Blood Flow Metab. 1992;12:817822.[Medline] [Order article via Infotrieve]
16. Turner R, Le Bihan D. Single-shot diffusion imaging at 2.0 Tesla. J Magn Reson. 1990;86:445452.
17. van Gelderen P, de Vleeshouwer MHM, DesPres D, Pekar J, van Zijl PCM, Moonen CTW. Water diffusion and acute stroke. Magn Reson Med. 1994;31:154163.[Medline] [Order article via Infotrieve]
18. Dardzinski BJ, Sotak CH, Fisher M, Hasegawa Y, Li L, Minematsu K. Apparent diffusion coefficient mapping of experimental focal cerebral ischemia using diffusion-weighted echo-planar imaging. Magn Reson Med. 1993;30:318325.[Medline] [Order article via Infotrieve]
19.
Hamberg LM, Macfarlane R, Tasdemiroglu E, Boccalini P,
Hunter GJ, Belliveau JW, Moskowitz MA, Rosen BR. Measurement of
cerebrovascular changes in cats after transient ischemia using
dynamic magnetic resonance imaging. Stroke. 1993;24:444451.
20.
Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis
RL, Bartkowski HM. Evaluation of
2,3,5-triphenyltetrazolium chloride as a
stain for detection and quantification of experimental cerebral
infarction in rats. Stroke. 1986;17:13041308.
21.
Lin T-N, He YY, Wu G, Khan M, Hsu CY. Effect of brain
edema on infarct volume in a focal cerebral ischemia model in
rats. Stroke. 1993;24:117121.
22. Li F, Irie K, Anwer MS, Fisher M. Delayed triphenyltetrazolium chloride staining remains useful for evaluating cerebral infarct volume in a rat stroke model. J Cereb Blood Flow Metab. 1997;17:11321135.[Medline] [Order article via Infotrieve]
23.
Kuluz JW, Gregory GA, Han Y, Dietrich WD, Schleien CL.
Fructose-1,6-biphosphate reduces infarct volume after reversible middle
cerebral artery occlusion in rats. Stroke. 1993;24:15761583.
24. Warner DS, Mcfarlane C, Todd MMT, Ludwig P, McAllister AM. Sevoflurane and halothane reduce focal ischemic brain damage in the rat: possible influence on thermoregulation. Anesthesiology. 1993;79:985992.[Medline] [Order article via Infotrieve]
25. Kiyota Y, Pahlmark K, Memezawa H, Smith M-L, Siesjö BK. Free radicals and brain damage due to transient middle cerebral artery occlusion: the effect of dimethylthiourea. Exp Brain Res. 1993;95:388396.[Medline] [Order article via Infotrieve]
26. McCook RD, Peiss CZN, Randall WC. Hypothalamic temperatures and blood flow. Proc Soc Exp Biol Med. 1962;109:518521.
27. Scremin OU. The vascular anatomy of the rat's hypothalamus in stereotaxic coordinates. J Comp Neurol. 1970;139:3152.[Medline] [Order article via Infotrieve]
28. Chen H, Chopp M, Zhang ZG, Garcia JH. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1992;12:612628.
29. Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, Chen S, Chopp M. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993;142:623635.[Abstract]
30. Busto R, Dietrich WD, Globus MY-T, Valdés I, Scheinberg P, Ginsberg MD. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab. 1987;7:729738.[Medline] [Order article via Infotrieve]
31. Morikawa E, Ginsberg MD, Dietrich WD, Duncan RC, Kraydieh S, Globus MY-T, Busto R. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1992;12:380389.[Medline] [Order article via Infotrieve]
32.
Kim Y, Busto R, Dietrich WD, Kraydieh S, Ginsberg MD.
Delayed postischemic hyperthermia in awake rats worsens the
histopathological outcome of transient focal cerebral ischemia.
Stroke. 1996;27:22742281.
33.
Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate
hyperglycemia augments ischemic brain damage: a neuropathologic
study in the rats. Neurology. 1982;32:12391246.
34. Gisselsson L, Smith M-L, Siesjö BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab. 1999;19:288297.[Medline] [Order article via Infotrieve]
Guest Editors, Departments of Neurological Surgery and Pediatrics, University of Miami School of Medicine, Miami, Florida
| Introduction |
|---|
|
|
|---|
Hyperthermia during and/or after a cerebral ischemic insult has been reported to worsen outcome after experimental ischemia and clinical stroke.2 3 As pointed out in the present study, the consequences of temperature elevations on ischemic outcome depend on multiple factors, including the severity of the insult, the duration of ischemia, and the degree of hyperthermia. In this study spontaneous hyperthermia did not increase infarct volume after permanent ischemia. As indicated by the authors, a reason for this result may be that permanent intraluminal suture MCAO produces an infarct volume that is maximal and therefore not sensitive to secondary injury mechanism, including postischemic hyperthermia. However, it should also be stressed that infarct volume was assessed at a 24-hour survival period. This is a relatively short survival period and may therefore not define the final histopathological outcome. From a clinical perspective, it would be important to assess the affects of spontaneous hyperthermia on chronic histopathological and behavioral outcome.
Evidence was also provided for a role of hypothalamic ischemic damage in the development of spontaneous hyperthermia. Possible mechanisms for spontaneous hyperthermia after ischemic damage may be complex and also involve the synthesis or activation of 1 or more endogenous pyrogens. For example, interleukin 1ß (IL-1ß) plays a key role in the regulation of body temperature under normal and pathological conditions.4 In addition, several studies have documented the upregulation of IL-1ß after brain ischemia.5 Whether treatment with an antibody to the IL-1ß receptor subtype IL-1RII6 would inhibit spontaneous hyperthermia under the present conditions remains to be determined. Novel strategies to prevent periods of hyperthermia after clinical stroke require continued investigation.
Received May 4, 1999; revision received August 2, 1999; accepted August 5, 1999.
| References |
|---|
|
|
|---|
2. Azzimondi G, Bassein L, Nonino F. Fever in acute stroke worsens prognosis: a prospective study. Stroke.. 1995;26:20402043.
3. Dietrich WD, Busto R. Hyperthermia and brain ischemia. In: Welch KMA, Reis DJ, Caplan LR, Siesjö BK, Weir B, eds. Primer on Cerebrovascular Diseases, San Diego, Calif: Academic Press; 1997:163165.
4.
Murakami N, Sukata Y, Watanbe T. Central action sites of
interleukin-1ß for inducing fever in rabbits. J
Physiol.. 1990;428:299312.
5. Minami M, Kuraishi Y, Yabuuchi K, Yamazaki A, Satoh M. Induction of interleukin-1ß in rat brain after transient global ischemia. J Neurochem.. 1992;58:390392.[Medline] [Order article via Infotrieve]
6.
Kent S, Bluthe RM, Dantzer R, Hardwick AJ, Kelly
KW, Rothwell NJ. Different receptor mechanisms mediate the pyrogenic
and behavioral effects of interleukin-1. Proc Natl Acad Sci.
U S A.. 1996;89:91179120.
This article has been cited by other articles:
![]() |
C. W. Hogue Jr, C. A. Palin, and J. E. Arrowsmith Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth. Analg., July 1, 2006; 103(1): 21 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, S.-J. Liu, J. Zhang, R. Strong, J. Aronowski, and J. C. Grotta Combining Insulin-Like Growth Factor Derivatives Plus Caffeinol Produces Robust Neuroprotection After Stroke in Rats Stroke, January 1, 2005; 36(1): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gerriets, E. Stolz, M. Walberer, C. Muller, C. Rottger, A. Kluge, M. Kaps, M. Fisher, and G. Bachmann Complications and Pitfalls in Rat Stroke Models for Middle Cerebral Artery Occlusion: A Comparison Between the Suture and the Macrosphere Model Using Magnetic Resonance Angiography Stroke, October 1, 2004; 35(10): 2372 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meisel, K. Prass, J. Braun, I. Victorov, T. Wolf, D. Megow, E. Halle, H.-D. Volk, U. Dirnagl, and A. Meisel Preventive Antibacterial Treatment Improves the General Medical and Neurological Outcome in a Mouse Model of Stroke Stroke, January 1, 2004; 35(1): 2 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Virtanen, J. Jolkkonen, J. Sivenius, M. Dittmar, and M. Horn Re: External Carotid Artery Territory Ischemia Impairs Outcome in the Endovascular Filament Model of Middle Cerebral Artery Occlusion in Rats * Response: Determinants of Body Weight Changes in the MCAO Filament Model Stroke, January 1, 2004; 35 (1): e9 - e10. [Full Text] [PDF] |
||||
![]() |
T. Gerriets, E. Stolz, M. Walberer, M. Kaps, G. Bachmann, and M. Fisher Neuroprotective Effects of MK-801 in Different Rat Stroke Models for Permanent Middle Cerebral Artery Occlusion: Adverse Effects of Hypothalamic Damage and Strategies for Its Avoidance Stroke, September 1, 2003; 34(9): 2234 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sulter, J. W. Elting, M. Langedijk, N. M. Maurits, and J. De Keyser Admitting Acute Ischemic Stroke Patients to a Stroke Care Monitoring Unit Versus a Conventional Stroke Unit: A Randomized Pilot Study Stroke, January 1, 2003; 34(1): 101 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takagi, G. Boysen, and H. Christensen Body Temperature in Acute Stroke * Response Stroke, September 1, 2002; 33(9): 2154 - 2155. [Full Text] [PDF] |
||||
![]() |
H. P. Grocott, G. B. Mackensen, A. M. Grigore, J. Mathew, J.G. Reves, B. Phillips-Bute, P. K. Smith, and M. F. Newman Postoperative Hyperthermia Is Associated With Cognitive Dysfunction After Coronary Artery Bypass Graft Surgery Stroke, February 1, 2002; 33(2): 537 - 541. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |